Issue 3/2008
Content (13 Articles)
Heart Group
A Statement on Ethics from the HEART Group
Editorial
Betablockers: Is the Reduction of Sudden Death Related to Pure Electrophysiologic Effects?
Antonio Berruezo, Josep Brugada
Electrophysiological Effects of Carvedilol Administration in Patients with Dilated Cardiomyopathy
Emmanuel M. Kanoupakis, Emmanuel G. Manios, Hercules E. Mavrakis, Eleftherios M. Kallergis, George M. Lyrarakis, Emmanuel P. Koutalas, Panos E. Vardas
Long-Term Nitrate Use in Acute Myocardial Infarction (The Heart Institute of Japan, Department of Cardiology Nitrate Evaluation Program)
Takao Yamauchi, Nobuhisa Hagiwara, Hiroshi Kasanuki, Ryo Koyanagi, Hiroshi Ogawa
Secondary Prevention After Acute Myocardial Infarction and Coronary Revascularisation: Focus on Angiotensin Converting Enzyme Inhibitors
Juan Carlos Kaski, Daniel Fernandez-Berges
Platelet Hyperaggregability: Impaired Responsiveness to Nitric Oxide (“Platelet NO Resistance”) as a Therapeutic Target
Sharmalar Rajendran, Yuliy Y. Chirkov
The Effect of Sulphonylureas on the Microvascular and Macrovascular Complications of Diabetes
Partha Kar, Richard I. G. Holt
Effect of Acarbose on Vascular Disease in Patients with Abnormal Glucose Tolerance
Markolf Hanefeld, Frank Schaper, Carsta Koehler
Effects of the Thiazolidinedione Medications on Micro- and Macrovascular Complications in Patients with Diabetes—Update 2008
Anand Rohatgi, Darren K. McGuire
Use of Insulin to Improve Glycemic Control in Diabetes Mellitus
Paresh Dandona, Ajay Chaudhuri, Husam Ghanim, Priya Mohanty